July 23, 2024CorporateMicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured AneurysmsMicroVention is Also Celebrating the Five-Year Anniversary of its WEB™ Aneurysm Embolization System with more than 10,000 Units Sold in the United States
July 11, 2024FinancialNotice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB)
July 11, 2024FinancialNotice Concerning the Issuance of Stock Options (Share Warrants) (PDF 114.67 KB)
Site Map Show — Site Map Hide — Site Map What’s new News Press Inquiries About Terumo Dear Stakeholders Who We Are Corporate Governance Compliance Regulations and Standards Procurement Activity At a Glance Terumo Group Identity Leadership Team History Terumo’s Purpose Terumo's Response to COVID-19 Education and Training Business Overview TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division Life Care Solutions Division Pharmaceutical Solutions Division Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies) Sustainability Sustainability News Sustainability at the Terumo Group Creating a Diverse and Inclusive Workplace Reducing Environmental Footprint Serving Our Communities Report Library GRI Standards Index Technology From Devices to Solutions Special Movies “Our Solutions” Terumo’s strengths—the 3Ds The Solutions Terumo Aims for Basic Information Research and Development Production and Supply Intellectual Property Investors Management Policy Management Policy Top Management Message Business Risks Disclaimer IR Policy IR Library Financial Statements Presentations Terumo Reports IR Events IR Inquiries Financial Highlights Shareholders & Stock Shareholders Meeting Stock Information Shareholder Return Credit Ratings and Corporate Bond Analyst Coverage Articles of Incorporation Site Quote Terms and Conditions of Use Privacy Policy Social Media Policy